U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Nucleic Acid Synthesis Inhibitors [Pharmacological Action]

Tree Number(s): D019384

MeSH Unique ID: D019384

  • 2,6-diaminopurine (Supplementary Concept)
  • sulfoquinovosyl diglyceride (Supplementary Concept)
  • 1-(beta-D-arabinofuranosyl)-5-ethyluracil (Supplementary Concept)
  • 9-beta-D-arabinofuranosylguanosine 5'-triphosphate (Supplementary Concept)
  • 1-beta-arabinofuranosyl-5-ethyluracil 5'-triphosphate (Supplementary Concept)
  • 1-beta-arabinofuranosyl-5-propyluracil-5'-triphosphate (Supplementary Concept)
  • 1-beta-arabinofuranosyl-5-butyluracil-5'-triphosphate (Supplementary Concept)
  • fialuridine (Supplementary Concept)
  • 5-(2-bromoethyl)-2'-deoxyuridine (Supplementary Concept)
  • 5-(2-chloroethyl)-2'-deoxyuridine (Supplementary Concept)
  • 4-n-butylanilino dATP (Supplementary Concept)
  • 5-(2-bromovinyl)uridine (Supplementary Concept)
  • 2',3'-dideoxyguanosine (Supplementary Concept)
  • arabinofuranosyl-E-5-iodovinyluracil (Supplementary Concept)
  • 3,4-di-O-galloyl-5-O-digalloylquinic acid (Supplementary Concept)
  • carbonyldiphosphonate (Supplementary Concept)
  • lobucavir (Supplementary Concept)
  • digallic acid (Supplementary Concept)
  • ganciclovir triphosphate (Supplementary Concept)
  • penciclovir triphosphate (Supplementary Concept)
  • 2-hexaprenylhydroquinone (Supplementary Concept)
  • 1-O-(6'-sulfo-alpha-D-glucopyranosyl)-2,3-di-O-phytanyl-sn-glycerol (Supplementary Concept)
  • N(2)-(4-n-butylphenyl)-2'--deoxyguanosine 5'-imidotriphosphate (Supplementary Concept)
  • lucidenic acid O (Supplementary Concept)
  • lucidenic lactone (Supplementary Concept)
  • polycitone A (Supplementary Concept)
  • sculezonone A (Supplementary Concept)
  • sculezonone B (Supplementary Concept)
  • Sch 725680 (Supplementary Concept)
  • 1-deoxyrubralactone (Supplementary Concept)
  • islatravir (Supplementary Concept)
  • G(8-5m)T (Supplementary Concept)
  • 5-((1-(2-bromobenzoyl)-5-chloro-1H-indol-3-yl)methylene)-2-thioxodihydropyrimidine-4,6(1H,5H)-dione (Supplementary Concept)
  • ITBA-16 (Supplementary Concept)
  • DAAP1 (Supplementary Concept)
  • Ibezapolstat (Supplementary Concept)
  • Amanitins (MeSH Term)
  • Anisomycin (MeSH Term)
  • Arabinofuranosylcytosine Triphosphate (MeSH Term)
  • Chromomycins (MeSH Term)
  • Dactinomycin (MeSH Term)
  • Dichlororibofuranosylbenzimidazole (MeSH Term)
  • Distamycins (MeSH Term)
  • Echinomycin (MeSH Term)
  • Edeine (MeSH Term)
  • Fusaric Acid (MeSH Term)
  • Hydroxyphenylazouracil (MeSH Term)
  • Hydroxyurea (MeSH Term)
  • Idoxuridine (MeSH Term)
  • Methotrexate (MeSH Term)
  • Methylazoxymethanol Acetate (MeSH Term)
  • Plicamycin (MeSH Term)
  • Zinostatin (MeSH Term)
  • Nitracrine (MeSH Term)
  • Nogalamycin (MeSH Term)
  • Novobiocin (MeSH Term)
  • Phleomycins (MeSH Term)
  • Rifampin (MeSH Term)
  • Rimantadine (MeSH Term)
  • Chromomycin A3 (MeSH Term)
  • Mercaptopurine (MeSH Term)
  • Cytochalasin D (MeSH Term)
  • Mitomycin (MeSH Term)
  • Fluoroquinolones (MeSH Term)
  • Alpha-Amanitin (MeSH Term)
  • Pemetrexed (MeSH Term)
  • Famciclovir (MeSH Term)
  • Telbivudine (MeSH Term)
  • emtricitabine tenofovir alafenamide (Supplementary Concept)
  • TSAO-T (Supplementary Concept)
  • 2'3'-didehydro-2'3'-dideoxyadenosine (Supplementary Concept)
  • L-697661 (Supplementary Concept)
  • atevirdine (Supplementary Concept)
  • 3'-azido-2',3'-dideoxy-5-iodouridine (Supplementary Concept)
  • lamivudine, zidovudine drug combination (Supplementary Concept)
  • adefovir (Supplementary Concept)
  • 3'-azido-3'-deoxyarabinothymidine (Supplementary Concept)
  • oltipraz (Supplementary Concept)
  • 6-(1-(2,6-difluorophenyl)ethyl)-2-(dimethylamino)-5-methylpyrimidin-4(3H)-one (Supplementary Concept)
  • 3'-deoxycytidine (Supplementary Concept)
  • 3'-fluoro-2',3'-dideoxyguanosine (Supplementary Concept)
  • 1-((2-hydroxyethoxy)methyl)-6-(phenylthio)thymine (Supplementary Concept)
  • loviride (Supplementary Concept)
  • emivirine (Supplementary Concept)
  • beta-lapachone (Supplementary Concept)
  • efavirenz (Supplementary Concept)
  • dexelvucitabine (Supplementary Concept)
  • 2-cyclopentylthio-6-(1-(2,6-difluorophenyl)ethyl)-3,4-dihydro-5-methylpyrimidin-4(3H)-one (Supplementary Concept)
  • capravirine (Supplementary Concept)
  • etravirine (Supplementary Concept)
  • ammonium trichloro(dioxoethylene-O,O'-)tellurate (Supplementary Concept)
  • 3'-azido-2',3'-dideoxy-5-methylcytidine (Supplementary Concept)
  • ulonivirine (Supplementary Concept)
  • efavirenz, lamivudine, tenofovir disoproxil fumarate drug combination (Supplementary Concept)
  • lamivudine, tenofovir disoproxil fumarate drug combination (Supplementary Concept)
  • stavudine, lamivudine, nevirapine drug combination (Supplementary Concept)
  • GS-9131 (Supplementary Concept)
  • abacavir (Supplementary Concept)
  • adefovir dipivoxil (Supplementary Concept)
  • R-82913 (Supplementary Concept)
  • XZ460 (Supplementary Concept)
  • XZ456 (Supplementary Concept)
  • XZ462 (Supplementary Concept)
  • Zidovudine (MeSH Term)
  • Dideoxynucleosides (MeSH Term)
  • Zalcitabine (MeSH Term)
  • Didanosine (MeSH Term)
  • Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination (MeSH Term)
  • Emtricitabine, Rilpivirine, Tenofovir Drug Combination (MeSH Term)
  • Emtricitabine (MeSH Term)
  • Rilpivirine (MeSH Term)
  • Tenofovir (MeSH Term)
  • Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination (MeSH Term)
  • Foscarnet (MeSH Term)
  • Stavudine (MeSH Term)
  • Lamivudine (MeSH Term)
  • Nevirapine (MeSH Term)
  • Delavirdine (MeSH Term)
  • Phosphonoacetic Acid (MeSH Term)

Supplemental Content

Loading ...